remifentanil requirements during liver transplantatio
Not Applicable
Completed
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0002870
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
from 20 to 70 yr old recipients who undergo liver transplantation at Samsung Medical Center
Exclusion Criteria
Patient refused
Patients with arrhythmia (SPI measurement is less accurate)
Patients with remifentanil allergy
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The comparison of amount of remifentanil used in patients with median modified end liver disease score(MELD); low v.s high
- Secondary Outcome Measures
Name Time Method Factors affecting SPI values (volume status-pulse pressure variation, pulmonary artery wedge pressure, end diastolic volume);The comparison of amount of remifentanil used is determined by dissection-anhepatic-reperfusion phase;The nociception level to surgical incision was evaluated by heart rate, blood pressure, and SPI